N,N-Dimethylethylamine Citrate

## The Rise of N,N-Dimethylethylamine Citrate in Sports Nutrition

In the ever-evolving landscape of sports nutrition and pre-workout supplementation, the search for the 'next big stimulant' is a constant arms race. Following the FDA's crackdown on powerful aliphatic amines like Ephedrine, 1,3-Dimethylamylamine (DMAA), and later 1,5-Dimethylhexylamine (DMHA), supplement formulators turned their attention to the phenethylamine class. Enter N,N-Dimethylethylamine Citrate, a compound frequently disguised on supplement labels under the botanical moniker 'Eria Jarensis Extract'.

Marketed as a natural neuromodulator capable of delivering intense euphoria, laser-like focus, and explosive energy, N,N-Dimethylethylamine Citrate has become a staple in 'hardcore' pre-workout formulas. However, behind the marketing claims lies a complex synthetic molecule with a pharmacological profile that demands respect, caution, and a deep understanding of human biochemistry.

## Biochemical Structure: What is N,N-Dimethylethylamine?

To understand how N,N-Dimethylethylamine Citrate works, one must first look at its parent molecule: Phenethylamine (PEA). PEA is an endogenous trace amine found naturally in the human brain, where it acts as a neuromodulator that promotes the release of dopamine and serotonin. When consumed orally as a supplement, standard PEA is almost entirely useless; it is rapidly destroyed in the gut and liver by the enzyme monoamine oxidase B (MAO-B) before it can reach the brain.

To bypass this biological defense mechanism, chemists modify the PEA structure. By adding two methyl groups to the terminal nitrogen atom, they create N,N-Dimethylphenethylamine (N,N-DMPEA). This N,N-dimethylation does two things: 1. **Increases Lipophilicity:** The molecule becomes more fat-soluble, allowing it to easily cross the blood-brain barrier. 2. **Provides Steric Hindrance:** The bulky methyl groups physically block MAO enzymes from easily breaking down the molecule, extending its half-life from a few minutes to roughly an hour or two.

The 'Citrate' portion of the name simply refers to the salt form of the molecule. Binding the active alkaloid to citric acid improves its solubility in water, making it easier to mix into pre-workout powders and enhancing its absorption in the gastrointestinal tract.

## Mechanism of Action: How It Hacks Your Neurochemistry

Once N,N-Dimethylethylamine Citrate crosses the blood-brain barrier, it acts as a powerful agonist at the trace amine-associated receptor 1 (TAAR1). TAAR1 is a crucial receptor located inside the presynaptic terminals of neurons that produce dopamine, norepinephrine, and serotonin.

When N,N-DMPEA binds to TAAR1, it triggers a cascade of intracellular events that results in the phosphorylation of monoamine transporters. Normally, these transporters act like vacuums, sucking neurotransmitters out of the synapse to end their signaling. TAAR1 activation causes these 'vacuums' to run in reverse. Instead of clearing dopamine and norepinephrine, they actively pump massive amounts of these neurotransmitters out into the synaptic cleft.

This flood of catecholamines is responsible for the acute effects users feel: * **Dopamine:** Drives the intense feelings of euphoria, motivation, and mood elevation. * **Norepinephrine:** Triggers the 'fight or flight' response, resulting in heightened alertness, increased heart rate, and enhanced physical energy.

## The 'Natural' Loophole: Eria Jarensis vs. Synthetic Reality

One of the most controversial aspects of N,N-Dimethylethylamine Citrate is how it is marketed. Many supplement companies list it on their labels as 'Eria Jarensis Extract', implying that it is a natural botanical ingredient sourced from an orchid species native to Southeast Asia.

This tactic is straight out of the industry playbook used for previous stimulants. DMAA was famously claimed to be a natural extract of geranium stems, while DMHA was claimed to come from aconite or walnut bark. In reality, laboratory analyses have repeatedly shown that the concentrations of these specific amines in the actual plants are either non-existent or so infinitesimally small that extracting them for commercial use would be economically impossible.

The N,N-Dimethylethylamine Citrate found in dietary supplements is almost certainly synthesized in a laboratory. The use of botanical names is a regulatory loophole designed to classify the synthetic drug as a 'dietary ingredient' under the Dietary Supplement Health and Education Act (DSHEA), despite it lacking a history of safe use in the food supply.

## Comparisons to Banned Stimulants: DMAA and DMHA

Because human clinical trials on N,N-Dimethylethylamine Citrate are virtually non-existent, health professionals and regulatory bodies often evaluate its safety by comparing it to structurally and functionally similar compounds that have extensive safety data—namely, DMAA and DMHA.

According to the FDA and medical resources like RxList and WebMD, DMAA and DMHA are potent sympathomimetics. They constrict blood vessels, raise blood pressure, and increase heart rate. The FDA has explicitly stated that DMAA can lead to cardiovascular problems ranging from shortness of breath and tightening in the chest to heart attacks and seizures.

While N,N-DMPEA has a slightly different chemical backbone (it is a phenethylamine rather than an aliphatic amine), its end result on the peripheral nervous system is highly similar. It triggers the release of norepinephrine, which binds to alpha and beta-adrenergic receptors, causing the exact same vasoconstriction and tachycardia seen with DMAA. Therefore, the safety warnings applied to DMAA and DMHA are highly relevant to users of N,N-Dimethylethylamine Citrate.

## Cardiovascular and Neurological Safety Risks

The primary danger of N,N-Dimethylethylamine Citrate lies in its cardiovascular strain. By artificially elevating blood pressure and heart rate, it places significant stress on the myocardium (heart muscle) and the vascular endothelium.

Individuals with pre-existing conditions such as hypertension, arrhythmias, or structural heart defects are at an exponentially higher risk of adverse events. Furthermore, because this ingredient is almost always combined with high doses of caffeine and other stimulants in pre-workout formulas, the synergistic effect on the cardiovascular system can be unpredictable and dangerous.

Neurologically, the rapid depletion of dopamine and norepinephrine can lead to a severe 'crash' once the drug wears off, characterized by lethargy, anhedonia (inability to feel pleasure), and irritability. Chronic use can lead to the downregulation of dopamine receptors, resulting in tolerance and a psychological dependence on the stimulant to achieve normal baseline energy levels.

## Dosing and Real-World Application

In the absence of clinical guidelines, dosing is largely based on anecdotal reports and industry standards found in product catalogs. The median dose found in commercial pre-workouts is 150mg, with a typical range of 150mg to 200mg.

Because of its short half-life, the effects of N,N-Dimethylethylamine Citrate hit hard and fast, usually within 15 to 30 minutes, but dissipate within 1 to 2 hours. To combat this, formulators often pair it with caffeine anhydrous (which has a half-life of 4-6 hours) to provide a sustained energy baseline as the euphoric effects of the DMPEA fade.

Consumers must exercise extreme caution when using products containing this ingredient. It is imperative to start with a fraction of the recommended dose to assess individual tolerance, avoid stacking it with other stimulant-containing products (including coffee or energy drinks), and cycle off the product regularly to prevent receptor downregulation and cardiovascular strain.